These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29370477)

  • 1. Prevalence and clinical outcomes of white-coat and masked hypertension: Analysis of a large ambulatory blood pressure database.
    Tocci G; Presta V; Figliuzzi I; Attalla El Halabieh N; Battistoni A; Coluccia R; D'Agostino M; Ferrucci A; Volpe M
    J Clin Hypertens (Greenwich); 2018 Feb; 20(2):297-305. PubMed ID: 29370477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease.
    Wang C; Zhang J; Li Y; Ma X; Ye Z; Peng H; Lou T
    Int J Cardiol; 2017 Mar; 230():33-39. PubMed ID: 28034462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients.
    Pierdomenico SD; Pierdomenico AM; Coccina F; Porreca E
    Am J Hypertens; 2017 Nov; 30(11):1106-1111. PubMed ID: 29059303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Masked hypertensives: A disguised arterial stiffness population.
    Antza C; Doundoulakis I; Stabouli S; Tziomalos K; Kotsis V
    J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1473-1480. PubMed ID: 31498516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.
    Sivén SS; Niiranen TJ; Kantola IM; Jula AM
    J Hypertens; 2016 Jan; 34(1):54-60. PubMed ID: 26630213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in diastolic function in masked hypertension: findings from the masked hypertension study.
    Oe Y; Shimbo D; Ishikawa J; Okajima K; Hasegawa T; Diaz KM; Muntner P; Homma S; Schwartz JE
    Am J Hypertens; 2013 Jun; 26(6):808-15. PubMed ID: 23446956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.
    Fujiwara T; Yano Y; Hoshide S; Kanegae H; Kario K
    JAMA Cardiol; 2018 Jul; 3(7):583-590. PubMed ID: 29800067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of the Home-Clinic Blood Pressure Difference: A Systematic Review and Meta-Analysis.
    Sheppard JP; Fletcher B; Gill P; Martin U; Roberts N; McManus RJ
    Am J Hypertens; 2016 May; 29(5):614-25. PubMed ID: 26399981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.
    Gijón-Conde T; Graciani A; López-García E; Guallar-Castillón P; García-Esquinas E; Rodríguez-Artalejo F; Banegas JR
    Hypertens Res; 2017 Jun; 40(6):613-619. PubMed ID: 28179625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term risk of sustained hypertension in white-coat or masked hypertension.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Polo Friz H; Grassi G; Sega R
    Hypertension; 2009 Aug; 54(2):226-32. PubMed ID: 19564548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients.
    Hwang ES; Choi KJ; Kang DH; Nam GB; Jang JS; Jeong YH; Lee CH; Lee JY; Park HK; Park CH
    Korean J Intern Med; 2007 Dec; 22(4):256-62. PubMed ID: 18309684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proportion of US Adults Recommended Out-of-Clinic Blood Pressure Monitoring According to the 2017 Hypertension Clinical Practice Guidelines.
    Booth JN; Hubbard D; Sakhuja S; Yano Y; Whelton PK; Wright JT; Shimbo D; Muntner P
    Hypertension; 2019 Aug; 74(2):399-406. PubMed ID: 31230550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific differences between conventional and ambulatory daytime blood pressure values.
    Conen D; Aeschbacher S; Thijs L; Li Y; Boggia J; Asayama K; Hansen TW; Kikuya M; Björklund-Bodegård K; Ohkubo T; Jeppesen J; Gu YM; Torp-Pedersen C; Dolan E; Kuznetsova T; Stolarz-Skrzypek K; Tikhonoff V; Schoen T; Malyutina S; Casiglia E; Nikitin Y; Lind L; Sandoya E; Kawecka-Jaszcz K; Mena L; Maestre GE; Filipovský J; Imai Y; O'Brien E; Wang JG; Risch L; Staessen JA
    Hypertension; 2014 Nov; 64(5):1073-9. PubMed ID: 25185130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis.
    Karnjanapiboonwong A; Anothaisintawee T; Chaikledkaew U; Dejthevaporn C; Attia J; Thakkinstian A
    BMC Cardiovasc Disord; 2020 Nov; 20(1):491. PubMed ID: 33225900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.
    Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA;
    Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.
    Ghazi L; Cohen LP; Muntner P; Shimbo D; Drawz PE
    Hypertension; 2020 Oct; 76(4):1090-1096. PubMed ID: 32829666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
    Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
    Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinic and ambulatory blood pressure in a population-based sample of African Americans: the Jackson Heart Study.
    Thomas SJ; Booth JN; Bromfield SG; Seals SR; Spruill TM; Ogedegbe G; Kidambi S; Shimbo D; Calhoun D; Muntner P
    J Am Soc Hypertens; 2017 Apr; 11(4):204-212.e5. PubMed ID: 28285829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.